June 10, 2024 – Page 6 – Goldea Capital

Sydbank share buyback programme: transactions in week 23

Written by Customer Service on June 10, 2024. Posted in Public Companies.

Company Announcement No 22/2024 Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk 10 June 2024 Dear Sirs Sydbank share buyback programme: transactions in week 23On 28 February 2024 Sydbank announced a share buyback programme of DKK 1,200m. The share buyback programme commenced on 4 March 2024 and will be completed by 31 January 2025. The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the share...

Nevada Copper Files for Chapter 11 Bankruptcy Protection

Written by Customer Service on June 10, 2024. Posted in Public Companies.

YERINGTON, Nev., June 10, 2024 (GLOBE NEWSWIRE) — Nevada Copper Corp. (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) and its subsidiaries (collectively, “Nevada Copper” or the “Company”) today announced that they have filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court of the District of Nevada. As disclosed in recent news releases and securities filings, the Company was in discussions with its key stakeholders and other parties to obtain funding and/or enter into a change of control transaction. However, those discussions have failed to result in obtaining such funding or other transaction, and the Company has been unable to secure additional interim funding from its key stakeholders. As a result, the Company is unable to continue carrying on business. In conjunction with the...

Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy

Written by Customer Service on June 10, 2024. Posted in Public Companies.

Improvements in multiple sign efficacy endpoints were observed in full population and with predictive and more pronounced effects in the TNFR1 genetic biomarker population as identified in prior successful Phase 2 symptoms trial Rapid treatment effect on corneal inflammation was observed in TNFR1 genetic biomarker patients as early as Day 15 and was statistically significant at final efficacy visit on Day 43 Licaminlimab was well tolerated similar to vehicle Company plans to finalize Phase 3 development plans following an End-of-Phase 2 (EoP2) meeting with the U.S. Food and Drug Administration (FDA) An investor and analyst webcast will be held today at 8:30am US Eastern Time ZUG, Switzerland, June 10, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to...

VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery Conference in Berlin

Written by Customer Service on June 10, 2024. Posted in Public Companies.

Berlin and Kyiv, 10 June 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that VEON, through its 100%-owned subsidiary Kyivstar, plans to increase its commitment to rebuild Ukraine’s digital infrastructure to USD 1 billion over the five-year period from 2023 through 2027. This is an increase from the previously announced USD 600 million investment commitment for the three-year period between. The commitment will fund investments into network and digital services, including potential acquisitions or the development of new assets, social contributions and partnerships. The Chairman of VEON board of directors and VEON founder Augie Fabela, VEON and Kyivstar board member and former U.S. Secretary of State Michael R. Pompeo, and Kyivstar...

Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy

Written by Customer Service on June 10, 2024. Posted in Public Companies.

Figure 1 – RELIEF Topline Results PR ZUG, Switzerland, June 10, 2024 (GLOBE NEWSWIRE) — Improvements in multiple sign efficacy endpoints were observed in full population and with predictive and more pronounced effects in the TNFR1 genetic biomarker population as identified in prior successful Phase 2 symptoms trial Rapid treatment effect on corneal inflammation was observed in TNFR1 genetic biomarker patients as early as Day 15 and was statistically significant at final efficacy visit on Day 43 Licaminlimab was well tolerated similar to vehicle Company plans to finalize Phase 3 development plans following an End-of-Phase 2 (EoP2) meeting with the U.S. Food and Drug Administration (FDA) An investor and analyst webcast will be held today at 8:30am US Eastern Time Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global...

Master the Complexities of International Mergers & Acquisitions with IBFD’s New Online Course!

Written by Customer Service on June 10, 2024. Posted in Mergers And Acquisitions.

Uncover the intricacies of international Mergers and Acquisitions (M&A) Gain in-depth knowledge on all stages of an M&A transaction Amsterdam, June 10, 2024 (GLOBE NEWSWIRE) — IBFD’s comprehensive online course, Mergers and Acquisitions – International Tax Aspects, helps you uncover the intricacies of international M&A transactions. Designed for tax professionals in multinational groups, advisory firms, and governments, this intermediate-level course equips you with the skills to navigate international M&A deals with confidence. Gain in-depth knowledge on all stages of an M&A transaction, from defining your strategy to post-closing integration. Explore the tax implications of various financing alternatives, identify tax pitfalls and opportunities, and master the role of representations, warranties,...

Form 8.5 (EPT/RI) – Touchstone Exploration Inc. AMENDMENT

Written by Customer Service on June 10, 2024. Posted in Mergers And Acquisitions.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Touchstone Exploration Inc (c) Name of the party to the offer with which exempt principal trader is connected: Touchstone Exploration Inc (d) Date dealing undertaken: 31 May 2024 (e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? Yes – Trinity Exploration & Production Plc 2. DEALINGS BY...

Form 8.5 (EPT/RI) – Touchstone Exploration Inc. AMENDMENT

Written by Customer Service on June 10, 2024. Posted in Mergers And Acquisitions.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Touchstone Exploration Inc (c) Name of the party to the offer with which exempt principal trader is connected: Touchstone Exploration Inc (d) Date dealing undertaken: 29 May 2024 (e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? Yes – Trinity Exploration & Production Plc 2. DEALINGS BY...

Form 8.5 (EPT/RI) – Touchstone Exploration Inc. AMENDMENT

Written by Customer Service on June 10, 2024. Posted in Mergers And Acquisitions.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Touchstone Exploration Inc (c) Name of the party to the offer with which exempt principal trader is connected: Touchstone Exploration Inc (d) Date dealing undertaken: 28 May 2024 (e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? Yes – Trinity Exploration & Production Plc 2. DEALINGS BY...

DFDS DIVESTS OSLO CRUISE FERRY ROUTE TO ENHANCE TRANSPORT FOCUS

Written by Customer Service on June 10, 2024. Posted in Public Companies.

INVESTOR NEWS no. 42 – 10 June 2024 DFDS has today entered into an agreement to divest the Oslo-Frederikshavn-Copenhagen (OFC) cruise ferry route to Gotlandsbolaget. Completion of the agreement is expected in October 2024. The OFC route annually carries more than 700,000 passengers between Norway and Denmark. The route deploys two cruise ferries and has just over 800 sea- and land-based employees. Revenue in 2023 was DKK 0.9bn equal to 3% of the DFDS Group’s total revenue. “It is with a heavy heart that we have found a new home for the Oslo route as it has been a part of DFDS since our foundation in 1866 and in addition a cherished public institution in Denmark and Norway. DFDS is however today a transport and logistics company bridging Europe and the route deserves a new owner that can continue to invest in and develop the...

Day: June 10, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice